SCHEMBL7423578

SCHEMBL7423578

Clc1cncc(-c2cccs2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.56
CYP2C9 P11712 2/20 0.56
CYP2E1 P05181 1/20 0.56
CYP2A6 P11509 1/20 0.56
CYP2B6 P20813 1/20 0.56
CYP17A1 P05093 1/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
KCNH2 Q12809 1/20 0.42
PDGFRB P09619 1/20 0.41
PDGFRA P16234 1/20 0.41
ROCK1 Q13464 1/20 0.41
KDM4E B2RXH2 3/20 0.41
HSD17B10 Q99714 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
RAB9A P51151 1/20 0.41
CHRNB1 P11230 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1357023 0.86 CYP2A6 (0.67) CYP3A4CYP2C9CYP2E1CYP2A6CYP2B6
SCHEMBL4347551 0.78 KCNH2 (0.48) CYP3A4CYP2C9CYP2E1CYP2A6CYP2B6
SCHEMBL4135591 0.78 CYP2A6 (0.56) CYP3A4CYP2C9CYP2E1CYP2A6CYP2B6
SCHEMBL30613331 0.78 CYP2A6 (0.56) CYP3A4CYP2C9CYP2E1CYP2A6CYP2B6
SCHEMBL12608111 0.78 CYP2A6 (0.56) CYP3A4CYP2C9CYP2E1CYP2A6CYP2B6
SCHEMBL12608100 0.78 CYP2E1 (0.56) CYP3A4CYP2C9CYP2E1CYP2A6CYP2B6
SCHEMBL4135586 0.78 CYP2C9 (0.56) CYP3A4CYP2C9CYP2E1CYP2A6CYP2B6
SCHEMBL26387047 0.78 CYP2E1 (0.56) CYP3A4CYP2C9CYP2E1CYP2A6CYP2B6
SCHEMBL7500094 0.77 CYP3A4 (0.51) CYP3A4CYP2C9CYP2E1CYP2A6CYP2B6
SCHEMBL25171070 0.75 CYP2E1 (0.49) CYP3A4CYP2C9CYP2E1CYP2A6CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1418882-A Substituted sulfonic acid N- [ (aminoiminomethyl) phenylalkyl ] -azacyclic amide compounds AVENTIS PHARMACENEITCALS INC (US) 2003-05-21 CN disclosed
CN-1093856-C Substituted sulfonic acid N- [ (aminoiminomethyl) phenylalkyl ] -azacyclic amide compounds AVENTIS PHARM PROD INC (US) 2002-11-06 CN disclosed
EP-0894088-A4 SUBSTITUTED SULFONIC ACID N- (AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLAMIDE COMPOUNDS RHONE POULENC RORER PHARMA (US) 2001-12-05 EP disclosed
US-6034093-A Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 2000-03-07 US disclosed
CN-1213370-A Substituted sulfonic acid N- [ (aminoiminomethyl) phenylalkyl ] -azacyclic amide compounds RHONE POULENC RORER PHAMACEUTI (US) 1999-04-07 CN disclosed
EP-0894088-A1 SUBSTITUTED SULFONIC ACID N- (AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLAMIDE COMPOUNDS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-02-03 EP disclosed
WO-1998024784-A1 SUBSTITUTED SULFONIC ACID N-[(AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLAMIDE COMPOUNDS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-06-11 WO disclosed
US-5731315-A Substituted sulfonic acid n- (aminoiminomethyl)phenylalkyl!-azaheterocyclamide compounds RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-03-24 US disclosed